NICHOLAS P ALVAREZ (Chief Acquisition Officer) sold 75,000 shares for an estimated $443,760 ERIC HAROLD YECIES (Chief Legal Officer & GC) sold 15,000 shares for an estimated $183,750 To track insider transactions, check out Quiver Quantitative's insider trading dashboard
Simultaneously, the original creators of our GLP-1s, Novo Nordisk and Eli Lilly, took an offensive strategy against the compounding industry
Their effects on the human body, legal status, and medical applications are actually quite distinct
That mindset is a common one Patients whove reached their health goals with GLP-1s arent just correcting things like volume loss or skin laxity, Heckmann said
Because the attractions between the particles are so similar, the freedom of movement of the ethanol molecules in the water solution is about the same as their freedom of movement in the pure ethanol